Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
A Comparison of Buprenorphine, Sustained release Buprenorphine, and High concentration Buprenorphine in Male New Zealand White RabbitsJournal of the American Association for Laboratory Animal Science, 2020-09, Vol.59 (5), p.546-556 [Peer Reviewed Journal]American Association for Laboratory Animal Science 2020 ;ISSN: 1559-6109 ;EISSN: 2769-6677 ;DOI: 10.30802/AALAS-JAALAS-19-000132 ;PMID: 32674750Full text available |
|
2 |
Material Type: Book
|
Crushed buprenorphine or buprenorphine-naloxone for opioid dependency :: a review of the clinical effectiveness and guidelinesDigital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
BuprenorphineActa crystallographica. Section E, Structure reports online, 2014-06, Vol.70 (Pt 6), p.o635-o635 [Peer Reviewed Journal]Mazurek et al. 2014 2014 ;ISSN: 1600-5368 ;EISSN: 1600-5368 ;DOI: 10.1107/S1600536814009672 ;PMID: 24940223Full text available |
|
4 |
Material Type: Book
|
Buprenorphine for chronic pain :: review of the clinical effectivenessDigital Resources/Online E-Resources |
|
5 |
Material Type: Book
|
Buprenorphine Formulations for the Treatment of Opioid Use DisordersDigital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
BuprenorphineBMJ supportive & palliative care, 2023-03, Vol.13 (1), p.125-126 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2045-435X ;EISSN: 2045-4368 ;DOI: 10.1136/spcare-2022-003954 ;PMID: 36585223Full text available |
|
7 |
Material Type: Article
|
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) studyAddiction (Abingdon, England), 2016-08, Vol.111 (8), p.1416-1427 [Peer Reviewed Journal]2016 Society for the Study of Addiction ;2016 Society for the Study of Addiction. ;ISSN: 0965-2140 ;EISSN: 1360-0443 ;DOI: 10.1111/add.13375 ;PMID: 26948856 ;CODEN: ADICE5Full text available |
|
8 |
Material Type: Article
|
Frontline Science: Buprenorphine decreases CCL2‐mediated migration of CD14+CD16+ monocytesJournal of leukocyte biology, 2018-12, Vol.104 (6), p.1049-1059 [Peer Reviewed Journal]2018 Society for Leukocyte Biology ;2018 Society for Leukocyte Biology. ;ISSN: 0741-5400 ;EISSN: 1938-3673 ;DOI: 10.1002/JLB.3HI0118-015R ;PMID: 29791013Full text available |
|
9 |
Material Type: Article
|
Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusersAddiction (Abingdon, England), 2010-04, Vol.105 (4), p.709-718 [Peer Reviewed Journal]2010 The Authors. Journal compilation © 2010 Society for the Study of Addiction ;2015 INIST-CNRS ;Journal compilation © 2010 Society for the Study of Addiction ;ISSN: 0965-2140 ;EISSN: 1360-0443 ;DOI: 10.1111/j.1360-0443.2009.02843.x ;PMID: 20403021 ;CODEN: ADICE5Full text available |
|
10 |
Material Type: Article
|
BuprenorphineCanadian family physician, 2011-03, Vol.57 (3), p.281-289 [Peer Reviewed Journal]ISSN: 0008-350X ;EISSN: 1715-5258Full text available |
|
11 |
Material Type: Article
|
Buprenorphine for managing opioid withdrawalCochrane database of systematic reviews, 2017-02, Vol.2017 (2), p.CD002025 [Peer Reviewed Journal]Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD002025.pub5 ;PMID: 28220474Full text available |
|
12 |
Material Type: Article
|
Perioperative Continuation of Buprenorphine at Low–Moderate Doses Was Associated with Lower Postoperative Pain Scores and Decreased Outpatient Opioid Dispensing Compared with Buprenorphine DiscontinuationPain medicine (Malden, Mass.), 2020-09, Vol.21 (9), p.1955-1960 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2020 Oxford University Press ;The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 1526-2375 ;EISSN: 1526-4637 ;DOI: 10.1093/pm/pnaa020 ;PMID: 32167541Full text available |
|
13 |
Material Type: Article
|
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin usersAddiction biology, 2015-07, Vol.20 (4), p.784-798 [Peer Reviewed Journal]2014 Society for the Study of Addiction ;2014 Society for the Study of Addiction. ;2015 Society for the Study of Addiction ;ISSN: 1355-6215 ;EISSN: 1369-1600 ;DOI: 10.1111/adb.12163 ;PMID: 25060839Full text available |
|
14 |
Material Type: Article
|
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorderActa obstetricia et gynecologica Scandinavica, 2023-03, Vol.102 (3), p.313-322 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). ;2022 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). ;2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0001-6349 ;EISSN: 1600-0412 ;DOI: 10.1111/aogs.14497 ;PMID: 36562462Full text available |
|
15 |
Material Type: Article
|
Primary Care and the Opioid-Overdose Crisis — Buprenorphine Myths and RealitiesThe New England journal of medicine, 2018-07, Vol.379 (1), p.1-4 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1802741 ;PMID: 29972748Full text available |
|
16 |
Material Type: Article
|
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone Soluble-FilmsClinical pharmacology and therapeutics, 2011-03, Vol.89 (3), p.443-449 [Peer Reviewed Journal]2011 American Society for Clinical Pharmacology and Therapeutics ;2015 INIST-CNRS ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1038/clpt.2010.352 ;PMID: 21270789 ;CODEN: CLPTATFull text available |
|
17 |
Material Type: Article
|
Barriers to Primary Care Physicians Prescribing BuprenorphineAnnals of family medicine, 2014-03, Vol.12 (2), p.128-133 [Peer Reviewed Journal]Annals of Family Medicine, Inc. ;2014 Annals of Family Medicine, Inc. 2014 ;ISSN: 1544-1709 ;EISSN: 1544-1717 ;DOI: 10.1370/afm.1595 ;PMID: 24615308Full text available |
|
18 |
Material Type: Article
|
When Prescribing Isn’t Enough — Pharmacy-Level Barriers to Buprenorphine AccessThe New England journal of medicine, 2020-08, Vol.383 (8), p.703-705 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2002908Full text available |
|
19 |
Material Type: Article
|
Buprenorphine versus Methadone in PregnancyThe New England journal of medicine, 2023-03, Vol.388 (10), p.957-958 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2300439 ;PMID: 36884334Full text available |
|
20 |
Material Type: Article
|
Extended-release monthly buprenorphine injectionCanadian Medical Association journal (CMAJ), 2023-01, Vol.195 (1), p.E14-E14 [Peer Reviewed Journal]COPYRIGHT 2023 CMA Impact Inc. ;Copyright CMA Impact, Inc. Jan 9, 2023 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.220730 ;PMID: 36623857Full text available |